Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 811 | 1087 | 761 | 1149 | 980 | 1866 |
Fund Return | -18.92% | 8.72% | -23.88% | 4.74% | -0.4% | 6.44% |
Place in category | 107 | 22 | 94 | 76 | 65 | 67 |
% in Category | 47 | 7 | 46 | 55 | 61 | 87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PIMegatrend Selection I USD | 12.06B | 6.56 | 1.38 | 7.67 | ||
PIMegatrend Selection P dy USD | 12.06B | 6.32 | 0.47 | 6.76 | ||
PIMegatrend Selection R USD | 12.06B | 6.08 | -0.43 | 5.80 | ||
Pictet Global Megatrend Selection P | 12.06B | 6.32 | 0.47 | 6.76 | ||
PIMegatrend Selection Z USD | 12.06B | 4.81 | 2.05 | 8.29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 105.94M | 4.88 | -4.60 | 3.64 | ||
Pictet Biotech PUSD | 1.48B | -18.50 | 5.47 | 7.18 | ||
Equities L Biotechnology Class I US | 1.45B | 2.72 | 2.18 | 7.26 | ||
Equities L Biotechnology Class R US | 1.45B | 2.99 | 2.98 | 7.71 | ||
Pictet Biotech I USD | 1.48B | 1.14 | -2.61 | 6.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Pictet-Short-Term Money Market USD Z | LU0222474172 | 6.83 | - | - | |
argenx ADR | US04016X1019 | 5.39 | 375.50 | +0.06% | |
Vertex | US92532F1003 | 4.01 | 392.81 | -0.86% | |
Alnylam | US02043Q1076 | 4.00 | 143.95 | -2.31% | |
Natera Inc | US6323071042 | 3.46 | 92.88 | -1.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Neutral | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review